{
  "id": 3858,
  "text": "1907.Smyth, E.C., Korpanty, G., McCaffrey, J.A., Mulligan, N.& Carney, D.N.Small-cell carcinoma of the cervix at 23 weeks gestation.J Clin Oncol 28, e295-297 (2010).1908.Tewari, K., et al.Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1907.Smyth, E.C., Korpanty, G., McCaffrey, J.A., Mulligan, N.& Carney, D.N.Small-cell carcinoma of the cervix at 23 weeks gestation.J Clin Oncol 28, e295-297 (2010).1908.Tewari, K., et al.Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including pl\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "治疗怀孕23周时被诊断为宫颈小细胞癌（局部晚期）的患者需要在评估肿瘤分期、妊娠期持续时间和母婴健康风险后制定个性化的治疗方案。以下是可能的治疗策略：\n\n1. **延迟治疗以保留妊娠**：在某些情况下，可选择新辅助化疗（NACT），以延缓放疗或手术的时间，直到胎儿达到相对成熟阶段（通常是妊娠32-34周）。新辅助化疗通常采用对胎儿毒性较小的药物，如顺铂联合依托泊苷或其他方案。此方法旨在控制肿瘤的扩展，同时尽量延长妊娠时间。\n\n2. **终止妊娠并立即开始治疗**：如果癌症进展迅速或母体生命受到威胁，可以考虑终止妊娠从而为放疗、同步化疗或手术争取时间。对于宫颈小细胞癌，由于其侵袭性强且易早期转移，早期干预可能提高总体生存率。\n\n3. **分期和风险评估**：对患者进行详细的分期评估（包括影像学和病理检测）至关重要，明确是否有远处转移。根据肿瘤分期选择治疗强度。\n\n4. **多学科协作**：需要由妇科肿瘤学、产科、新生儿科和肿瘤放化疗科携手制定个性化治疗方案。同时，应与患者充分沟通风险与获益，尊重其意愿。\n\n总之，这类患者的管理强调母婴利益平衡。治疗的选择取决于疾病进展、妊娠周数和患者的个人偏好，结合医学和伦理考量以作出最佳决策。",
  "query": "如果一名怀孕23周的女性被诊断出宫颈小细胞癌，应该考虑哪些治疗方案，尤其是在妊娠期局部晚期宫颈癌的管理中？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如果一名怀孕23周的女性被诊断出宫颈小细胞癌，应该考虑哪些治疗方案，尤其是在妊娠期局部晚期宫颈癌的管理中？\n\n<reference text>: 1907.Smyth, E.C., Korpanty, G., McCaffrey, J.A., Mulligan, N.& Carney, D.N.Small-cell carcinoma of the cervix at 23 weeks gestation.J Clin Oncol 28, e295-297 (2010).1908.Tewari, K., et al.Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "治疗怀孕23周时被诊断为宫颈小细胞癌（局部晚期）的患者需要在评估肿瘤分期、妊娠期持续时间和母婴健康风险后制定个性化的治疗方案。以下是可能的治疗策略：\n\n1. **延迟治疗以保留妊娠**：在某些情况下，可选择新辅助化疗（NACT），以延缓放疗或手术的时间，直到胎儿达到相对成熟阶段（通常是妊娠32-34周）。新辅助化疗通常采用对胎儿毒性较小的药物，如顺铂联合依托泊苷或其他方案。此方法旨在控制肿瘤的扩展，同时尽量延长妊娠时间。\n\n2. **终止妊娠并立即开始治疗**：如果癌症进展迅速或母体生命受到威胁，可以考虑终止妊娠从而为放疗、同步化疗或手术争取时间。对于宫颈小细胞癌，由于其侵袭性强且易早期转移，早期干预可能提高总体生存率。\n\n3. **分期和风险评估**：对患者进行详细的分期评估（包括影像学和病理检测）至关重要，明确是否有远处转移。根据肿瘤分期选择治疗强度。\n\n4. **多学科协作**：需要由妇科肿瘤学、产科、新生儿科和肿瘤放化疗科携手制定个性化治疗方案。同时，应与患者充分沟通风险与获益，尊重其意愿。\n\n总之，这类患者的管理强调母婴利益平衡。治疗的选择取决于疾病进展、妊娠周数和患者的个人偏好，结合医学和伦理考量以作出最佳决策。"
}